March 2021

Andre Argenton is the Vice President of Core R&D at the Dow Chemical Company. He oversees a broad portfolio of corporate research programs and world leading innovation capabilities that enable technology development across multiple key market segments.

Previously, Andre was the global R&D director of Industrial Intermediates & Infrastructure. His responsibilities included managing the innovation pipeline across multiple chemistry envelopes including Polyurethanes and Industrial Solutions.

Argenton earned a...Read more

Mike Tomasco is a Vice President in Pfizer Digital with responsibility for leading Pfizer Global Supply’s (PGS) Digital Transformation. The goal of the program is to transform PGS through a business strategy driven focus on digitization applied end to end across Manufacturing and Supply Operations. Mr. Tomasco has experience across strategy, marketing, finance, manufacturing and information systems for multinational companies and has successfully led several major transformational initiatives.

Prior to his current role...Read more

Karolin Luger is the Jennie Smoly Caruthers Endowed Chair of Biochemistry at the University of Colorado in Boulder, and an Investigator for the Howard Hughes Medical Institute. She is a biochemist and structural biologist recognized for her work on chromatin structure and function. Luger was a key player in efforts to elucidate the three-dimensional structure of the nucleosome, the basic repeating unit in chromatin.  Her lab’s current work focuses on how nucleosomes are recognized, assembled, and remodeled, and how nucleosome dynamics affect gene expression. The group also studies the...Read more